This post was just published on ZYX Buy Change Alert. SCO hedge is from $25.87. As of this writing it is trading at $93.25. Back in 2014, we called for hedging part of the portfolio with inverse ETF SCO for the very long-term. There are huge profits on this hedge. Profits have
This post was just published on ZYX Buy Change Alert. This morning we have received many questions on DUST. DUST is a triple leveraged inverse precious metal miner ETF. We have given trades on DUST in this service before. As a full disclosure, there are substantial precious metal short positions in ZYX
In her much anticipated speech at the Federal Reserve Bank of Kansas City Symposium at Jackson Hole, Wyoming, Janet Yellen was wishy-washy, making stocks, bonds, gold and currencies vulnerable. The title of here speech was “The Federal Reserve’s Monetary Policy Toolkit: Past, Present and Future.” Absent from her toolkit is
In her much-anticipated speech at the Federal Reserve Bank of Kansas City Symposium at Jackson Hole, Wyo. on Friday, Janet Yellen started out by eloquently making a clear case for a Fed interest-rate hike. Then it seems she couldn’t help herself and turned wishy-washy. Yellen’s wishy-washiness has made the markets
This post was just published on ZYX Buy Change Alert. RAX is a cloud hosting company. It has received a $32 cash buyout offer from APO. The offer is likely to close in the fourth quarter of this year. There is about 30% probability of a strategic competing bidder to emerge.
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the
This post was just published on ZYX Buy Change Alert. We have very intelligent subscribers. We have received many emails asking about buying ahead of Yellen’s speech. Our subscribers are correct that Yellen has traditionally been dovish and if she is dovish again the market is likely to go up. In
This post was just published on ZYX Buy Change Alert. MYL is primarily a drug manufacturer but also has a few branded products like EpiPen. The stock has been under pressure because of controversial price increase on EpiPen. As of this writing the stock has broken support at $45 on Clinton
When almost everyone is positioned one way and the news shows the positioning is wrong, tremendous investment opportunity is created. Late last year and earlier this year, such an opportunity was created due to combination of the Federal Reserve raising interest rates for the first time since the Great Recession
This post was just published on ZYX Buy Change Alert. For us to recommend, a stock must pass at least four of the six screens. We prefer a stock to meet all six screens. Our rigorous criteria has led to enviable performance over a long period of time. We periodically provide